In this issue:
Niraparib in platinum-sensitive, recurrent ovarian cancer
Preoperative assessment of lymph node metastasis in endometrial cancer
p16INK4A as a biomarker of cervical carcinogenesis or of malignant potential
HPV/cytology cervical cotesting at 3-year intervals and impact on cervical cancer risk
Utility of postoperative vaginal brachytherapy for early stage endometrial cancer
Use and effectiveness of neoadjuvant chemotherapy for ovarian cancer
Quality of life during olaparib maintenance therapy in ovarian cancer
Effect of maintenance olaparib on overall survival in patients with platinum-sensitive recurrent serous ovarian cancer
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy
Global trends and predictions in ovarian cancer mortality
The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy
Clinical outcome of patients with advanced epithelial ovarian cancer in complete response after PDS + chemotherapy or neoadjuvant chemotherapy followed by IDS
Combined chemotherapy and radiotherapy vs chemotherapy alone for uterine serous carcinoma
Please login below to download this issue (PDF)